Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 66898-62-2
2. Somalgen
3. Lomucin
4. Talniflumato
5. Ba 7602-06
6. Ba-7602-06
7. Phthalidyl 2-(3-trifluoromethylanilino)nicotinate
8. Ba7602-06; Somalgen
9. Jfk78s0u9s
10. [(1r)-3-oxo-1h-2-benzofuran-1-yl] 2-[3-(trifluoromethyl)anilino]pyridine-3-carboxylate
11. 3-phthalidyl Ester Of 2-((3-(trifluoromethyl)phenyl)amino)-3-pyridinecarboxylic Acid
12. Ncgc00167754-01
13. 3-ftalidilico Del Acido 2-((3-(trifluormetil)fenil)amino)-3-piridincarboxilico
14. (3-oxo-1h-2-benzofuran-1-yl) 2-[3-(trifluoromethyl)anilino]pyridine-3-carboxylate
15. Dsstox_cid_26740
16. Dsstox_rid_81869
17. Dsstox_gsid_46740
18. 2-[[3-(trifluoromethyl)phenyl]amino]-3-pyridinecarboxylic Acid 1,3-dihydro-3-oxo-1-isobenzofuranyl Ester
19. Talniflumatum
20. Talniflumate [usan:inn]
21. Talniflumatum [inn-latin]
22. Talniflumato [inn-spanish]
23. 3-pyridinecarboxylic Acid, 2-((3-(trifluoromethyl)phenyl)amino)-, 1,3-dihydro-3-oxo-1-isobenzofuranyl Ester
24. Cas-66898-62-2
25. Unii-jfk78s0u9s
26. Brn 0503261
27. Somalgen (tn)
28. 3-pyridinecarboxylic Acid, 2-[[3-(trifluoromethyl)phenyl]amino]-, 1,3-dihydro-3-oxo-1-isobenzofuranyl Ester
29. Phthalidyl 2-(alpha,alpha,alpha-trifluoro-m-toluidino)nicotinate
30. Talniflumate [mi]
31. Talniflumate (usan/inn)
32. Talniflumate [inn]
33. 2-(alpha,alpha,alpha-trifluoro-m-toluidino)nicotinic Acid Phthalidyl Ester
34. Talniflumate [usan]
35. 3-ftalidilico Del Acido 2-((3-(trifluormetil)fenil)amino)-3-piridincarboxilico [spanish]
36. Schembl23691
37. Talniflumate [mart.]
38. Talniflumate [who-dd]
39. Chembl1081506
40. Dtxsid3046740
41. Chebi:91991
42. Hms3269m13
43. Hms3413d19
44. Hms3677d19
45. Msi-1995
46. Phthalidyl 2-(alpha,alpha,alpha,-trifluoro-m-toluidino)nicotinate
47. Tox21_112584
48. Mfcd00866135
49. S6439
50. Akos015895754
51. Tox21_112584_1
52. Db09295
53. Ks-5130
54. Nicotinic Acid, 2-(alpha,alpha,alpha-trifluoro-m-toluidino)-, Phthalidyl Ester
55. Ncgc00167754-02
56. Ac-14144
57. Db-054972
58. Hy-103370
59. Cs-0027765
60. Ft-0630769
61. T3101
62. D02701
63. T72807
64. 898t622
65. A835581
66. Brd-a98378129-001-01-4
67. Q22075910
68. Phthalidyl 2-(3'-trifluormethylanilino)-pyridin-3-carboxylate
69. Phthalidyl 2-(3-trifluoromethylanilino)-3-pyridinecarboxylate
70. Phthalidyl 2-(.alpha.,.alpha.,.alpha.-trifluoro-m-toluidino)nicotinate
71. 2-(.alpha.,.alpha.,.alpha.-trifluoro-m-toluidino)nicotinic Acid Phthalidyl Ester
72. 3-oxo-1,3-dihydroisobenzofuran-1-yl 2-(3-(trifluoromethyl)phenylamino)nicotinate
73. Nicotinic Acid, 2-(.alpha.,.alpha.,.alpha.-trifluoro-m-toluidino)-, Phthalidyl Ester
74. (3-oxo-1h-isobenzofuran-1-yl) 2-[3-(trifluoromethyl)anilino]pyridine-3-carboxylate;talniflumate
75. 2-[[3-(trifluoromethyl)phenyl]amino]-1,3-dihydro-3-oxo-1-isobenzofuranyl 3-pyridinecarboxylic Acid Ester
76. 2-[3-(trifluoromethyl)anilino]-3-pyridinecarboxylic Acid (3-oxo-1h-isobenzofuran-1-yl) Ester
| Molecular Weight | 414.3 g/mol |
|---|---|
| Molecular Formula | C21H13F3N2O4 |
| XLogP3 | 5.3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 5 |
| Exact Mass | 414.08274139 g/mol |
| Monoisotopic Mass | 414.08274139 g/mol |
| Topological Polar Surface Area | 77.5 Ų |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 644 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Talnifumate is a phthalidyl ester of nifumic acid, which has potent analgesic and anti-inflammatory effects and is widely used to treat inflammatory disorders, such as rheumatoid arthritis and osteoarthritis, and has also been studied for the management of cystic fibrosis.
Talniflumate is metabolized to its prodrug, niflumic acid, which has several pharmacodynamic effects. Firstly, it blocks synthesis of mucin. Secondly, talniflumate blocks prostaglandin synthesis by cyclooxygenases, which aids in pain and inflammation management.
Volume of Distribution
In 12 subjects after a single oral administration, total plasma clearance of the main metabolite, niflumic acid, averaged 45 ml/min giving a distribution volume of 0.12 l/kg on average.
Clearance
This drug undergoes extensive first pass effect.
Extensive liver metabolism.
Approximately 2h in 12 subjects
Talniflumate is a strong and selective inhibitor of core mucin-synthesizing enzyme GCNT3 (core 2 b-1,6 N-acetylglucosaminyltransferase). Talniflumate decreases gene expression of GCNT3 and production of mucins in vivo and in vitro. Talniflumate improves response of pancreatic tumors to gefitinib (chemotherapy drug). Talniflumate is a strong calcium-activated chloride channel (CaCC) blocker.
Market Place
ABOUT THIS PAGE
A Talniflumate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Talniflumate, including repackagers and relabelers. The FDA regulates Talniflumate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Talniflumate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Talniflumate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Talniflumate supplier is an individual or a company that provides Talniflumate active pharmaceutical ingredient (API) or Talniflumate finished formulations upon request. The Talniflumate suppliers may include Talniflumate API manufacturers, exporters, distributors and traders.
click here to find a list of Talniflumate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Talniflumate Drug Master File in Korea (Talniflumate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Talniflumate. The MFDS reviews the Talniflumate KDMF as part of the drug registration process and uses the information provided in the Talniflumate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Talniflumate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Talniflumate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Talniflumate suppliers with KDMF on PharmaCompass.
Talniflumate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Talniflumate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Talniflumate GMP manufacturer or Talniflumate GMP API supplier for your needs.
A Talniflumate CoA (Certificate of Analysis) is a formal document that attests to Talniflumate's compliance with Talniflumate specifications and serves as a tool for batch-level quality control.
Talniflumate CoA mostly includes findings from lab analyses of a specific batch. For each Talniflumate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Talniflumate may be tested according to a variety of international standards, such as European Pharmacopoeia (Talniflumate EP), Talniflumate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Talniflumate USP).
LOOKING FOR A SUPPLIER?
